You are here

  • Home
  • Archive
  • Volume 27, Issue 4
  • Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

Article metrics

Article menu
Evidence synthesis
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: October 2021 to March 2024

AbstractFullPdf
Oct 2021762755230
Nov 2021655639258
Dec 202128727988
Jan 202221021367
Feb 202216116255
Mar 202219420150
Apr 202213714752
May 202216415740
Jun 2022888629
Jul 202234631364
Aug 202236234389
Sep 202231129885
Oct 202213111150
Nov 202212511137
Dec 20221119952
Jan 202312810962
Feb 202312010551
Mar 2023827237
Apr 2023605440
May 2023837049
Jun 202313814479
Jul 2023938236
Aug 2023765333
Sep 2023453019
Oct 2023664921
Nov 202317014846
Dec 202312712453
Jan 2024816242
Feb 20241149724
Mar 20241207690
Total554751891928